Pages that link to "Q30375302"

The following pages link to EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. (Q30375302):

Displaying 18 items.

• MicroRNAs in Atrial Fibrillation: from Expression Signatures to Functional Implications. (Q41332557) (← links)
• Left atrial remodeling: Regional differences between paroxysmal and persistent atrial fibrillation (Q42266021) (← links)
• Newly developed atrial fibrillation progresses to a more severe INTERMACS score in a patient with advanced heart failure due to dilated cardiomyopathy (Q47097637) (← links)
• Transesophageal echocardiographic thromboembolic risk is associated with smoking status in patients with atrial fibrillation (Q47122860) (← links)
• A case of atrial cardiomyopathy in a patient with rheumatic heart disease with massive left atrial calcification. (Q48134571) (← links)
• Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure (Q50077869) (← links)
• Interatrial block and atrial remodeling assessed using speckle tracking echocardiography. (Q50324268) (← links)
• Left Atrium Wall-mapping Application for Wall Thickness Visualisation. (Q52665747) (← links)
• Differentiation and quantification of fibrosis, fat and fatty fibrosis in human left atrial myocardium using ex vivo MRI (Q57182092) (← links)
• Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction (Q58759117) (← links)
• and Are Affected by Stretch in HL-1 Atrial Myocytes (Q60950054) (← links)
• Heart Rhythm Insights Into Structural Remodeling in Atrial Tissue: Timed Automata Approach (Q61448840) (← links)
• Biomarkers of Atrial Fibrillation: Which One Is a True Marker? (Q64090263) (← links)
• Prognostic significance of atrial fibrillation in acute decompensated heart failure with reduced versus preserved ejection fraction (Q89483513) (← links)
• Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation (Q89613974) (← links)
• The role of fibroblast - Cardiomyocyte interaction for atrial dysfunction in HFpEF and hypertensive heart disease (Q90039918) (← links)
• Left Atrial Structural Remodelling in Non-Valvular Atrial Fibrillation: What Have We Learnt from CMR? (Q90047558) (← links)
• Effect of sepsis on the action potential and cardiac serotonin response in rats (Q92889801) (← links)